Results 81 to 90 of about 33,270 (306)
Revista de la Facultad de Medicina Humana, 2018 Objetivo: Identificar las características clínico oncológicas y sobrevida global en pacientes con tumor testicular de células germinales seminoma y no seminoma.
Robert Malpartida Palomino +1 more
doaj +1 more source
Unusual case of classic testicular seminoma in a 90-year-old patient: a case report
Journal of Medical Case Reports, 2020 Background Seminoma is the most common subtype of testicular cancer and occurs most commonly in patients aged 30–49 years, but decreases to a very low level in men in their 60s or older. Case presentation A 90-year-old Syrian man with a 6-year history of
Ahmad Al-Mousa +5 more
doaj +1 more source
Retroperitoneal germ cell tumor, primary or secondary: A diagnostic conundrum
MGM Journal of Medical Sciences, 2023 Germ cell tumor, seminoma, is the most common cancer in young men’s testis. However, a small subset of tumors (1%–2%) originate in other locations and are referred to as primary extragonadal germ cell tumors. But such type of tumors’ origin is thought to
Surabhi Singh +4 more
doaj +1 more source
The treatment of stage A testicular seminoma by carboplatin monochemotherapy [PDF]
, 2009 Background/Aim. Although radiotherapy is considered to be a standard treatment of stage A testicular seminoma, an increasing number of studies have reported encouraging results of the treatment by carboplatin monochemotherapy (CBDCA).
Bojanić Nebojša +4 more
core +1 more source
Histopathology, EarlyView.FH immunohistochemistry is recommended in clinically malignant Leydig cell tumours and in primary Leydig cell tumours with aggressive histopathologic features. Aims Testicular sex cord‐stromal tumours (TSCSTs) are relatively rare, accounting for ~5% of all testicular neoplasms.
Andres M Acosta +21 more
wiley +1 more source
Long-term cardiovascular complications in stage I seminoma patients
Clinical and Translational Oncology, 2017 PurposeThe cure rate of stage I seminoma patients is close to 100% and so the recent focus of clinical research has shifted onto the prevention of treatment-related complications.
A. Terbuch +13 more
semanticscholar +1 more source
International Journal of Urology, EarlyView.ABSTRACT Introduction Retroperitoneal lymph node dissection (RPLND) may be considered after chemotherapy or as primary treatment in patients with metastatic testicular cancer. We aimed to perform a systematic review to analyze outcomes in survivors across the domains of sexual, physical, and psychological function.
Gavin G. Calpin +4 more
wiley +1 more source
TDRG1 functions in testicular seminoma are dependent on the PI3K/Akt/mTOR signaling pathway
OncoTargets and Therapy, 2016 Human testis development-related gene 1 (TDRG1) is a recently identified gene that is expressed exclusively in the testes and promotes the development of testicular germ cell tumors.
Yong Wang +7 more
semanticscholar +1 more source
Germ cell and other tumors in individuals with differences in sex development
CA: A Cancer Journal for Clinicians, EarlyView.Abstract Approximately one in 3500 to one in 5100 live‐born infants have atypical external genital development, known as differences in sex development (DSD). In 2005, an expert consensus conference thoroughly reviewed aspects of health care for individuals with DSD.
Selma Feldman Witchel +1 more
wiley +1 more source
Clusterin suppresses invasion and metastasis of testicular seminoma by upregulating COL15a1
Molecular Therapy: Nucleic Acids, 2021 Seminoma is the most common subtype of testicular germ cell tumor, with an increasing incidence worldwide. Clusterin (CLU) expression was found to be downregulated in testicular seminoma in our previous study. We now expanded the sample size, and further
Yankang Cui +14 more
doaj